<!DOCTYPE html
  PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:n1="urn:hl7-org:v3">
   <head>
      <meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
   
      <title>Prostate Cancer:  Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients</title><style type="text/css">
body {
	color: rgb(26, 26, 26);
	background-color: rgb(255,255,255);
	font-family: Verdana, Tahoma, sans-serif;
	font-size: 11px;
}

a {
	color: rgb(0, 0, 255);
	background-color: rgb(255,255,255);
}

h1 {
	font-size: 12pt;
	font-weight: bold;
}

h2 {
	font-size: 11pt;
	font-weight: bold;
}

h3 {
	font-size: 10pt;
	font-weight: bold;
}

h4 {
	font-size: 8pt;
	font-weight: bold;
}

div {
	width: 80%;
}

table {
	line-height: 10pt;
	width: 80%;
}

tr {
	background-color: rgb(224,224,224);
}

td {
	padding: 0.1cm 0.2cm;
	vertical-align: top;
}

.h1center {
	font-size: 12pt;
	font-weight: bold;
	text-align: center;
	width: 80%;
}

.header_table{
	border: 1pt inset rgb(0,0,0);
}

.narr_table {
	width: 100%;
}

.narr_tr {
	background-color: rgb(225,225,225);
}
pre {
 overflow: auto; /* Use horizontal scroller if needed; for Firefox 2, not needed in Firefox 3 */
 white-space: pre-wrap; /* css-3 */
 white-space: -moz-pre-wrap !important; /* Mozilla, since 1999 */
 white-space: -pre-wrap; /* Opera 4-6 */
 white-space: -o-pre-wrap; /* Opera 7 */
 word-wrap: break-word; /* Internet Explorer 5.5+ */
 font-family: Verdana, Tahoma, sans-serif;
 font-size: 11px;
 text-align:left;
 margin: 0px 0px 0px 0px;
 padding:0px 0px 0px 0px;
}
.narr_th {
	background-color: rgb(201,201,201);
}

.td_label{
	font-weight: bold;
	color: white;
}
	</style></head>
   <body>
      <h1 class="h1center">Prostate Cancer:  Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients (NQF 0389)</h1>
      <table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Name</span></td>
               <td width="30%">Prostate Cancer:  Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Id</span></td>
               <td width="30%"> 77D11C01-F4C2-4006-AFED-4EBFFAF27D55</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Version number</span></td>
               <td width="30%">1</td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">eMeasure Set Id</span></td>
               <td width="30%"> B2E593F4-44F7-4E78-B565-DB6128A15617</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Available Date</span></td>
               <td width="30%"> No information </td>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement Period</span></td>
               <td>January 1, 20xx  through December 31, 20xx </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure Steward</span></td>
               <td width="80%" colspan="3">American Medical Association - Physician Consortium for Performance Improvement</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Endorsed by</span></td>
               <td width="80%" colspan="3">National Quality Forum</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Description</span></td>
               <td width="80%" colspan="3">Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low risk of recurrence receiving interstitial
                  prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy who did not
                  have a bone scan performed at any time since diagnosis of prostate cancer
               </td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Copyright</span></td>
               <td width="80%" colspan="3"><pre>&copy; 2010 American Medical Association.&nbsp;All Rights Reserved</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure scoring</span></td>
               <td width="80%" colspan="3">Proportion</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure type</span></td>
               <td width="80%" colspan="3">Process</td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Stratification</span></td>
               <td width="80%" colspan="3"><pre>None</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Risk Adjustment</span></td>
               <td width="80%" colspan="3"><pre>None</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Data Aggregation</span></td>
               <td width="80%" colspan="3"><pre></pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Rationale</span></td>
               <td width="80%" colspan="3"><pre>A bone scan is generally not required for staging prostate cancer in men with a low risk of recurrence and receiving primary therapy. This measure is written as a negative measure so that the performance goal is 100%, consistent with the other measures for this condition.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Clinical Recommendation Statement</span></td>
               <td width="80%" colspan="3"><pre>Routine use of a bone scan is not required for staging asymptomatic men with clinically localized prostate cancer when their PSA is equal to or less than 20.0 ng/mL (AUA).
Patients with a life expectancy of greater than 5 years or symptomatic:
&#8226; A bone scan is appropriate for T1 to T2 disease in the presence of a PSA greater than 20 ng/mL, Gleason score of 8 or higher, clinical stage of T3 to T4, or symptomatic disease.  
&#8226; Patients at higher risk of metastatic disease may undergo pelvic computed tomography (CT) or magnetic resonance imaging (MRI) scanning with possible fine-needle aspiration of enlarged lymph nodes or staging lymph node dissection. Nomograms or risk tables may be used to identify patients with a higher likelihood of having metastatic disease. If the nomogram indicates a probability of lymph node involvement greater than 20% or if the patient is stage T3 or T4, this is recommended as a threshold for doing a staging CT scan or MRI evaluation.
For all other patients, no additional imaging is required for staging (NCCN) (Category 2A).</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Improvement notation</span></td>
               <td width="80%" colspan="3"><pre>Higher score indicates better quality</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measurement duration</span></td>
               <td width="80%" colspan="3"><pre>12 month(s)</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3"><pre>National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology: Prostate Cancer. Version 2.2005. Available at: www.nccn.org/professionals/physician_gls/default.asp.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Reference</span></td>
               <td width="80%" colspan="3"><pre>American Urological Association (AUA). Guidelines for the management of clinically localized prostate cancer: 2006 update. 2006. American Urological Association Education and Research, Inc. DRAFT copy.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Initial Patient Population(s): Patient Age:  All patients regardless of age.
Diagnosis Active:  Patient has a documented diagnosis of prostate cancer.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator(s): All patients, regardless of age, with a diagnosis of prostate cancer at low risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator Exclusion(s): N/A</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Numerator(s): Patients who did not have a bone scan performed at any time since diagnosis of prostate cancer.</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Definition</span></td>
               <td width="80%" colspan="3"><pre>Denominator Exception(s): Documentation of medical reason(s) for performing a bone scan (including documented pain, salvage therapy, other medical reasons)
Documentation of system reason(s) for performing a bone scan (including bone scan ordered by someone other than reporting physician).</pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Guidance</span></td>
               <td width="80%" colspan="3"><pre></pre></td>
            </tr>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Supplemental Data Elements</span></td>
               <td width="80%" colspan="3"><pre>Report "Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"; Report "Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"; Report "Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"; Report "Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)".</pre></td>
            </tr>
         </tbody>
      </table>
      <h2><a name="toc">Table of Contents</a></h2>
      <ul>
         <li><a href="#d2143e361">Population criteria</a></li>
         <li><a href="#d2143e1223">Data criteria (QDM Data Elements)</a></li>
         <li><a href="#d2143e1578">Supplemental Data Elements</a></li>
      </ul>
      <hr align="left" color="teal" size="2" width="80%">
      <h3><a name="d2143e361" href="#toc">Population criteria</a></h3>
      <div>
         
         <ul>
            <li>
               <b>Initial Patient Population =</b>
               
               <ul>
                  <li>AND: 
                     <ul>
                        <li>AND: "Diagnosis, Active: Prostate Cancer"</li>
                        <li>AND: "Patient Characteristic: Gender Male"</li>
                        <li> starts before or during "Measurement period"</li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator =</b>
               
               <ul>
                  <li>AND: "Initial Patient Population"</li>
                  <li>AND: "Procedure, Performed: Prostate Cancer Treatment" during "Measurement period"</li>
                  <li>AND: "Procedure, Performed: Clinical Staging Procedure (result: 'Tumor Stage T1c, T2a')" starts before or during ("Procedure,
                     Performed: Prostate Cancer Treatment" during "Measurement period")
                  </li>
                  <li>AND: "Laboratory Test, Result: Prostate Specific Antigen Test (result &lt;= 20.0 ng/mL)" starts before or during ("Procedure,
                     Performed: Prostate Cancer Treatment" during "Measurement period")
                  </li>
                  <li>AND: 
                     <ul>
                        <li>OR: "Laboratory Test, Result: Gleason Score &lt;= 6" starts before or during ("Procedure, Performed: Prostate Cancer Treatment"
                           during "Measurement period")
                        </li>
                        <li>OR: "Laboratory Test, Result: Gleason Score (result &lt;= 6 )" starts before or during ("Procedure, Performed: Prostate Cancer
                           Treatment" during "Measurement period")
                        </li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exclusions =</b>
               
               <ul>
                  <li>None</li>
               </ul>
               
            </li>
            <li>
               <b>Numerator =</b>
               
               <ul>
                  <li>AND NOT: "Diagnostic Study, Performed: Bone Scan" starts after start of ("Diagnosis, Active: Prostate Cancer" starts before
                     or during "Measurement period")
                  </li>
               </ul>
               
            </li>
            <li>
               <b>Denominator Exceptions =</b>
               
               <ul>
                  <li>AND: 
                     <ul>
                        <li>OR: "Diagnosis, Active: Pain Related to prostate cancer"</li>
                        <li>OR: "Procedure, Performed: Salvage Therapy"</li>
                        <li>OR: "Diagnostic Study, Performed: Bone Scan (reason)"</li>
                        <li> starts after start of  ("Diagnosis, Active: Prostate Cancer" starts before or during "Measurement period")</li>
                     </ul>
                     
                  </li>
               </ul>
               
            </li>
         </ul>
         
      </div>
      <h3><a name="d2143e1223" href="#toc">Data criteria (QDM Data Elements)</a></h3>
      <div>
         
         <ul>
            <li>
               "Diagnosis, Active: Pain Related to prostate cancer" using "Pain Related to prostate cancer Value Set GROUPING (2.16.840.1.113883.3.526.03.451)"
            </li>
            <li>
               "Diagnosis, Active: Prostate Cancer" using "Prostate Cancer Value Set GROUPING (2.16.840.1.113883.3.526.03.319)"
            </li>
            <li>
               "Diagnostic Study, Performed: Bone Scan" using "Bone Scan Value Set GROUPING (2.16.840.1.113883.3.526.03.320)"
            </li>
            <li>
               "Laboratory Test, Result: Gleason Score" using "Gleason Score Value Set GROUPING (2.16.840.1.113883.3.526.03.397)"
            </li>
            <li>
               "Laboratory Test, Result: Gleason Score &lt;= 6" using "Gleason Score &lt;= 6 SNOMED-CT Value Set (2.16.840.1.113883.3.526.02.280)"
            </li>
            <li>
               "Laboratory Test, Result: Prostate Specific Antigen Test" using "Prostate Specific Antigen Test Value Set GROUPING (2.16.840.1.113883.3.526.03.401)"
            </li>
            <li>
               "Patient Characteristic: Gender Male" using "Gender Male HL7 Value Set (2.16.840.1.113883.1.11.1)"
            </li>
            <li>
               "Procedure, Performed: Clinical Staging Procedure" using "Clinical Staging Procedure SNOMED-CT Value Set (2.16.840.1.113883.3.526.02.1027)"
            </li>
            <li>
               "Procedure, Performed: Prostate Cancer Treatment" using "Prostate Cancer Treatment Value Set GROUPING (2.16.840.1.113883.3.526.03.398)"
            </li>
            <li>
               "Procedure, Performed: Salvage Therapy" using "Salvage Therapy Value Set GROUPING (2.16.840.1.113883.3.526.03.399)"
            </li>
            <li>
               Attribute: "Result: Tumor Stage T1c, T2a" using "Tumor Stage T1c, T2a SNOMED-CT Value Set  (2.16.840.1.113883.3.526.02.286)"
            </li>
         </ul>
         
      </div>
      <h3><a name="d2143e1578" href="#toc">Supplemental Data Elements</a></h3>
      <div>
         
         <ul>
            <li>"Patient Characteristic: Gender" using "Gender HL7 Value Set (2.16.840.1.113883.1.11.1)"</li>
            <li>"Patient Characteristic: Race" using "Race CDC Value Set (2.16.840.1.114222.4.11.836)"</li>
            <li>"Patient Characteristic: Ethnicity" using "Ethnicity CDC Value Set (2.16.840.1.114222.4.11.837)"</li>
            <li>"Patient Characteristic: Payer" using "Payer Source of Payment Typology Value Set (2.16.840.1.113883.3.221.5)"</li>
         </ul>
         
      </div><br><hr align="left" color="teal" size="2" width="80%"><br><table class="header_table">
         <tbody>
            <tr>
               <td width="20%" bgcolor="#656565" style="background-color:#656565"><span class="td_label">Measure set</span></td>
               <td colspan="3">CLINICAL QUALITY MEASURE SET 2011-2012</td>
            </tr>
         </tbody>
      </table>
   </body>
</html>